ポリメラーゼ連鎖反応 (PCR) の各種技術と世界の市場

世界のポリメラーゼ連鎖反応 (PCR) の市場規模は、2023年の91億米ドルから、予測期間中は6.7%のCAGRで推移し、2028年には126億米ドルの規模に成長すると予測されています。

定量リアルタイムPCR (qPCRおよびRT-qPCR) の部門は、2023年の32億米ドルから、8.4%のCAGRで推移し、2028年には48億米ドルに達すると予測されています。また、マルチプレックスPCRの部門は、2023年の15億米ドルから、9.6%のCAGRで推移し、2028年には24億米ドルに達すると予測されています。

当レポートでは、世界のポリメラーゼ連鎖反応 (PCR) の市場を調査し、市場の定義・概要、市場影響因子および市場機会の分析、市場規模の推移・予測、各種区分・地域別の詳細分析、技術・特許の動向、ESGの展開、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 サマリー・ハイライト

• 市場の見通し
• PCR市場のハイライト

第3章 市場概要

• 概要
• PCRの進化
• PCRの原理
• PCRの機器とコンポーネント
• 機器
• ターゲットDNA
• プライマー
• 酵素と酵素濃度
• バッファー
• マグネシウム濃度
• デオキシリボヌクレオシド三リン酸
• 従来型PCRとリアルタイムPCR
• PCR用プライマーの設計
• プライマーの選択
• プライマーの長さ
• 融点
• 特異性
• G/Cコンテンツ
• 3'エンドシーケンス
• PCR定量法
• 絶対定量
• 相対定量
• 定量PCRの構成要素
• DNA結合色素
• qPCRにおけるプローブ
• qPCR実験のコントロール

第4章 市場力学

• 市場促進要因
• COVID-19
• 技術の進歩
• 臨床診断における需要の増大
• ゲノムおよびバイオマーカー研究の成長
• 産業用途における堅調な需要
• 市場の課題
• 高い投資コスト
• 訓練を受けた専門家の不足
• 技術的な限界と代替技術との競合
• 厳しい規制状況
• 主要因子・市場への影響

第5章 市場内訳：技術別

• 市場概要
• 標準PCR (PCR)
• 逆転写PCR (RT-PCR)
• 定量リアルタイムPCR
• 定量リアルタイムPCR (qPCR)
• 定量リアルタイム逆転写PCR (RT-qPCR)
• マルチプレックスPCR
• デジタルPCR (dPCR)
• その他のPCR技術
• ネステッド
• タッチダウン
• ホットスタート
• インバースPCR
• 市場収益：技術別
• 定量リアルタイムPCR (qPCRおよびRT-qPCR)
• 標準PCR
• 逆転写PCR (RT-PCR)
• マルチプレックスPCR
• デジタルPCR (dPCR)
• その他のPCR

第6章 市場内訳：製品別

• 市場概要
• PCRの世界市場 (製品別)
• 機器
• 市場概要
• 市場収益：タイプ別
• 市場収益：地域別
• 試薬・消耗品
• 市場概要
• 市場収益：タイプ別
• 市場収益：地域別
• ソフトウェア・サービス
• 市場概要
• 市場収益：タイプ別
• 市場収益：地域別

第7章 市場内訳：用途別

• 概要
• 基礎研究用途
• 市場概要
• 市場収益：地域別
• 臨床用途
• 市場概要
• 市場収益：地域別
• 産業用途
• 市場概要
• 市場収益：地域別

第8章 市場内訳：地域別

• 市場概要
• 市場収益：地域別
• 北米
• 市場収益：国別
• 欧州
• 市場収益：国別
• アジア太平洋
• 市場収益：国別
• その他の地域

第9章 ESGの発展

• ESG：イントロダクション
• PCR業界の持続可能性：ESGの観点から
• 主要な環境問題
• 業界のESGパフォーマンス分析
• BCCによる総論

第10章 新たな技術と開発

• 概要
• デジタルPCR
• マルチプレックスPCR症候群検査
• PCR検査：ポイントオブケアと分散型
• 等温核酸増幅技術 (INAAT)
• PCR自動化

第11章 特許分析

• 特許
• PubMed

第12章 競合情報

• 概要
• 機器
• 試薬・消耗品・付属品
• 主要企業
• M&A

第13章 企業プロファイル

• ABBOTT
• AGILENT TECHNOLOGIES, INC.
• BECTON, DICKINSON AND CO.
• BIOMERIEUX
• BIO-RAD LABORATORIES INC.
• DANAHER
• EPPENDORF SE
• EUROFINS SCIENTIFIC
• F. HOFFMANN-LA ROCHE LTD.
• HOLOGIC
• MERCK KGAA
• QIAGEN
• STANDARD BIOTOOLS INC.
• SYSMEX INOSTICS, INC.
• TAKARA BIO INC.
• THERMO FISHER SCIENTIFIC INC.

第14章 付録：頭字語

List of Tables

• Summary Table : Global Market for PCR, by Technique, Through 2028
• Table 1 : Traditional vs. Real-Time PCR
• Table 2 : Advantages and Disadvantages of Dye-Based Detection
• Table 3 : NGS vs. qPCR: A Detailed Comparison
• Table 4 : Factors Impacting PCR Market
• Table 5 : Standard PCR vs. RT-PCR
• Table 6 : Traditional PCR vs. Real-Time PCR vs. Digital PCR: at a Glance
• Table 7 : Common PCR Techniques and Their Core Benefits
• Table 8 : Global Market for PCR, by Technique, Through 2028
• Table 9 : Global Market for PCR, by Product, Through 2028
• Table 10 : Global Market for PCR Instruments, by Type, Through 2028
• Table 11 : Global Market for PCR Instruments, by Region, Through 2028
• Table 12 : North American Market for PCR Instruments, by Country, Through 2028
• Table 13 : European Market for PCR Instruments, by Country, Through 2028
• Table 14 : Asia-Pacific Market for PCR Instruments, by Country, Through 2028
• Table 15 : Global Market for PCR Reagents and Consumables, by Type, Through 2028
• Table 16 : Global Market for PCR Reagents and Consumables, by Region, Through 2028
• Table 17 : North American Market for PCR Reagents and Consumables, by Country, Through 2028
• Table 18 : European Market for PCR Reagents and Consumables, by Country, Through 2028
• Table 19 : Asia-Pacific Market for PCR Reagents and Consumables, by Country, Through 2028
• Table 20 : Global Market for PCR Software and Services, by Type, Through 2028
• Table 21 : Global Market for PCR Software and Services, by Region, Through 2028
• Table 22 : North American Market for PCR Software and Services, by Country, Through 2028
• Table 23 : European Market for PCR Software and Services, by Country, Through 2028
• Table 24 : Asia-Pacific Market for PCR Software and Services, by Country, Through 2028
• Table 25 : Global Market for PCR, by Application, Through 2028
• Table 26 : Global Market for PCR in Basic Research Applications, by Region, Through 2028
• Table 27 : North American Market for PCR in Basic Research Applications, by Country, Through 2028
• Table 28 : European Market for PCR in Basic Research Applications, by Country, Through 2028
• Table 29 : Asia-Pacific Market for PCR in Basic Research Applications, by Country, Through 2028
• Table 30 : Global Market for PCR in Clinical Applications, by Region, Through 2028
• Table 31 : North American Market for PCR in Clinical Applications, by Country, Through 2028
• Table 32 : European Market for PCR in Clinical Applications, by Country, Through 2028
• Table 33 : Asia-Pacific Market for PCR in Clinical Applications, by Country, Through 2028
• Table 34 : Common Industrial Uses of PCR Testing
• Table 35 : Global Market for PCR in Industrial Applications, by Region, Through 2028
• Table 36 : North American Market for PCR in Industrial Applications, by Country, Through 2028
• Table 37 : European Market for PCR in Industrial Applications, by Country, Through 2028
• Table 38 : Asia-Pacific Market for PCR in Industrial Applications, by Country, Through 2028
• Table 39 : Global Market for PCR, by Region, Through 2028
• Table 40 : North American Market for PCR, by Country, Through 2028
• Table 41 : European Market for PCR, by Country, Through 2028
• Table 42 : Asia-Pacific Market for PCR, by Country, Through 2028
• Table 43 : Key Environmental Issues in the PCR Industry
• Table 44 : Key Social and Governance Issues in the PCR Industry
• Table 45 : Net-Zero GHG Commitments, by Major PCR Companies
• Table 46 : Global ESG Score for Major PCR Companies, 2022 and 2023
• Table 47 : Commercial PCR Systems for Near Patient Testing
• Table 48 : Patents Granted to Major PCR Companies in the U.S. Patent Office
• Table 49 : PubMed Article Count: "RT-PCR" vs. "qPCR" vs. "dPCR" between 2010-2022
• Table 50 : Leading Players' Market Ranking in the PCR Market, 2022
• Table 51 : Selected Mergers and Acquisitions in PCR Industry, Jan 2021-Aug. 2023
• Table 52 : Abbott Laboratories: Company Snapshot
• Table 53 : Abbott Laboratories: Financials, 2022
• Table 54 : Abbott Laboratories: PCR Product Portfolio
• Table 55 : Abbott Laboratories: Selected Key Developments, Jan 2021-August 2023
• Table 56 : Agilent: Company Snapshot
• Table 57 : Agilent: Financials, 2022
• Table 58 : Agilent: PCR Product Portfolio
• Table 59 : Agilent: Selected Key Developments, Jan 2021-August 2023
• Table 60 : BD: Company Snapshot
• Table 61 : BD: Financials, 2022
• Table 62 : BD: PCR Product Portfolio
• Table 63 : BD: Selected Key Developments, Jan 2021-August 2023
• Table 64 : bioMerieux S.A.: Company Snapshot
• Table 65 : bioMerieux: Financials, 2022
• Table 66 : bioMerieux: PCR Product Portfolio
• Table 67 : bioMerieux: News/Key Developments, Jan 2021-May 2023
• Table 68 : Bio-Rad Laboratories Inc.: Company Snapshot
• Table 69 : Bio-Rad Laboratories Inc.: Financials, 2022
• Table 70 : Bio-Rad Laboratories Inc.: PCR Product Portfolio
• Table 71 : Bio-Rad Laboratories Inc.: Selected Key Developments, Jan 2021-August 2023
• Table 72 : Danaher: Company Snapshot
• Table 73 : Danaher: Financials, 2022
• Table 74 : Danaher: PCR Product Portfolio
• Table 75 : Danaher: News/Key Developments, Jan 2021-May 2023
• Table 76 : Eppendorf: Company Snapshot
• Table 77 : Eppendorf: Financials, 2022
• Table 78 : Eppendorf: PCR Product Portfolio
• Table 79 : Eppendorf: Selected Key Developments, Jan 2021-August 2023
• Table 80 : Eurofins Scientific: Company Snapshot
• Table 81 : Eurofins Scientific: Financials, 2022
• Table 82 : Eurofins Scientific: PCR Product Portfolio
• Table 83 : Eurofins Scientific: News/Key Developments, Jan 2021-May 2023
• Table 84 : Roche: Company Snapshot
• Table 85 : Roche: Financials, 2022
• Table 86 : Roche: PCR Product Portfolio
• Table 87 : Roche: News/Key Developments, Jan 2021–May 2023
• Table 88 : Hologic: Company Snapshot
• Table 89 : Hologic: Financials, 2022
• Table 90 : Hologic: PCR Product Portfolio
• Table 91 : Hologic: News/Key Developments, Jan 2021-May 2023
• Table 92 : Merck KGaA: Company Snapshot
• Table 93 : Merck: Financials, 2022
• Table 94 : Merck: PCR Product Portfolio
• Table 95 : Qiagen: Company Snapshot
• Table 96 : Qiagen: Financials, 2022
• Table 97 : Qiagen: PCR Product Portfolio
• Table 98 : Qiagen: News/Key Developments, Jan 2021-May 2023
• Table 99 : Standard BioTools: Company Snapshot
• Table 100 : Standard BioTools: Financials, 2022
• Table 101 : Standard BioTools: PCR Product Portfolio
• Table 102 : Standard BioTools: Selected Key Developments, Jan 2021-July 2023
• Table 103 : Sysmex Inostics: Selected Key Developments, April 2020-July 2023
• Table 104 : Takara Bio Inc.: Company Snapshot
• Table 105 : Takara Bio Inc.: Financials, 2023
• Table 106 : Takara Bio Inc.: PCR Product Portfolio
• Table 107 : Takara Bio Inc.: News/Key Developments, Jan 2021-May 2023
• Table 108 : Thermo Fisher Scientific Inc.: Company Snapshot
• Table 109 : Thermo Fisher Scientific Inc.: Segment Information
• Table 110 : Thermo Fisher Scientific Inc.: Financials, 2022
• Table 111 : Thermo Fisher Scientific Inc.: PCR Portfolio
• Table 112 : Thermo Fisher Scientific Inc.: News/Key Developments, Jan 2021-July 2023
• Table 113 : Major Acronyms Used in This Report

List of Figures

• Summary Figure A : Global Market for PCR, by Technique, 2020-2028
• Summary Figure B : Global Market Shares of PCR, by Technique, 2022
• Figure 1 : Standard PCR Workflow
• Figure 2 : What the Pandemic Meant for IVD Companies: Key Trends
• Figure 3 : Regulatory Requirements for Laboratory Products
• Figure 4 : Advantages of Multiplex PCR
• Figure 5 : Advantages of Different PCR Methods
• Figure 6 : Global Market for PCR, by Technique, 2020-2028
• Figure 7 : Global Market Shares of PCR, by Technique, 2022
• Figure 8 : Global Market for PCR, by Product, 2020-2028
• Figure 9 : Global Market Shares of PCR, by Product, 2022
• Figure 10 : Global Market for PCR Instruments, by Type, 2020-2028
• Figure 11 : Global Market Shares of PCR Instruments, by Type, 2022
• Figure 12 : Global Market for PCR Reagents and Consumables, by Type, 2020-2028
• Figure 13 : Global Market Shares of PCR Reagents and Consumables, by Type, 2022
• Figure 14 : Global Market for PCR Software and Services, by Type, 2020-2028
• Figure 15 : Global Market Shares of PCR Software and Services, by Type, 2022
• Figure 16 : Global Market for PCR, by Application, 2020-2028
• Figure 17 : Global Market Shares of PCR, by Application, 2022
• Figure 18 : Global Market for PCR, by Region, 2020-2028
• Figure 19 : Global Market Shares of PCR, by Region, 2022
• Figure 20 : Benefits of a Strong ESG Proposition
• Figure 21 : Share of the Total U.S. Greenhouse Gas Emissions, by Economic Sector, 2021
• Figure 22 : Emerging Trends/Technologies in the PCR Market
• Figure 23 : PubMed Article Count: "Digital PCR (dPCR)", 2010-2022
• Figure 24 : Point of Care Benefits
• Figure 25 : Share of "Polymerase chain reaction" or "PCR" Patents, by Assignee Country, 2020-2023*
• Figure 26 : PubMed Article Count: "RT-PCR" vs. "qPCR" vs. "dPCR" between 2010-2022
• Figure 27 : Abbott Laboratories: Financials, 2021 and 2022
• Figure 28 : Abbott Laboratories: Revenue Share, by Business Unit, 2022
• Figure 29 : Abbott Laboratories: Revenue Share, by Region, 2022
• Figure 30 : Agilent: Financials, 2021 and 2022
• Figure 31 : Agilent: Revenue Share, by Business Segment, 2022
• Figure 32 : Agilent: Revenue Share, by Region, 2022
• Figure 33 : BD: Financials, 2021 and 2022
• Figure 34 : BD: Market Share, by Segment, 2022
• Figure 35 : BD: Revenue Share, by Region, 2022
• Figure 36 : bioMerieux: Annual Revenue, 2021 and 2022
• Figure 37 : bioMerieux: Market Share, by Application Segment, 2022
• Figure 38 : bioMerieux: Revenue Share, by Region, 2022
• Figure 39 : Bio-Rad Laboratories Inc.: Financials, 2021 and 2022
• Figure 40 : Bio-Rad Laboratories Inc.: Market Share, by Business Segment, 2022
• Figure 41 : Bio-Rad Laboratories Inc.: Revenue Share, by Region, 2022
• Figure 42 : Danaher: Financials, 2021 and 2022
• Figure 43 : Danaher: Market Share, by Business Segment, 2022
• Figure 44 : Danaher: Revenue Share, by Region, 2022
• Figure 45 : Eppendorf: Financials, 2021 and 2022
• Figure 46 : Eppendorf: Market Share, by Business Division, 2022
• Figure 47 : Eppendorf: Revenue Share, by Region, 2022
• Figure 48 : Eurofins Scientific: Financials, 2021 and 2022
• Figure 49 : Eurofins Scientific: Market Share, by Major Service Lines, 2022
• Figure 50 : Eurofins Scientific: Revenue Share, by Region, 2022
• Figure 51 : Roche: Financials, 2021 and 2022
• Figure 52 : Roche: Market Share, by Business Segment, 2022
• Figure 53 : Hologic: Financials, 2021 and 2022
• Figure 54 : Hologic: Market Share, by Business Segment, 2022
• Figure 55 : Hologic: Revenue Share, by Region, 2022
• Figure 56 : Merck: Financials, 2021 and 2022
• Figure 57 : Merck: Market Share, by Business Segment, 2022
• Figure 58 : Merck: Revenue Share, by Region, 2022
• Figure 59 : Qiagen: Financials, 2021 and 2022
• Figure 60 : Qiagen: Market Share, by Product Group, 2022
• Figure 61 : Qiagen: Revenue Share, by Region, 2022
• Figure 62 : Standard BioTools: Financials, 2021 and 2022
• Figure 63 : Standard BioTools: Market Share, by Product Type, 2022
• Figure 64 : Standard BioTools: Revenue Share, by Region, 2022
• Figure 65 : Takara Bio Inc.: Annual Revenue, 2022 and 2023
• Figure 66 : Takara Bio Inc.: Market Share, by Business Segment, 2023
• Figure 67 : Takara Bio Inc.: Revenue Share, by Region, 2023
• Figure 68 : Thermo Fisher Scientific Inc.: Financials, 2021 and 2022
• Figure 69 : Thermo Fisher Scientific Inc.: Market Share, by Business Segment, 2022
• Figure 70 : Thermo Fisher Scientific Inc.: Revenue Share, by Region, 2022

Highlights:

The global market for polymerase chain reaction (PCR) is estimated to increase from $9.1 billion in 2023 to reach $12.6 billion by 2028, at a compound annual growth rate (CAGR) of 6.7% from 2023 through 2028.

Quantitative real-time PCR (qPCR and RT-qPCR) market is estimated to increase from $3.2 billion in 2023 to reach $4.8 billion by 2028, at a compound annual growth rate (CAGR) of 8.4% from 2023 through 2028.

Multiplex PCR market is estimated to increase from $1.5 billion in 2023 to reach $2.4 billion by 2028, at a compound annual growth rate (CAGR) of 9.6% from 2023 through 2028.

Report Scope:

This research study analyzes the PCR market, offers revenue forecasts, assesses future trends, and provides strategic recommendations for the success of market participants. The scope of the study is global. This report estimates market data for 2022 (the base year) and forecasts for 2023 through 2028. Figures for 2023 are estimated, except where actual results are reported. This report includes forecasts by product type, technique, application, and region from 2023 through 2028.

The report also analyzes leading and emerging competitors in the current worldwide PCR market.

Report Includes:

• 49 data tables and 65 additional tables
• An overview and up-to-date analysis of the global markets for the polymerase chain reaction (PCR) technologies
• Analyses of the global market trends, with historical market revenue data (sales figures) from 2021 to 2022, estimates for 2023, forecasts for 2024, and projections of compound annual growth rates (CAGRs) through 2028
• Estimate of the actual market size and revenue forecast for the PCR markets in USD millions, and corresponding market share analysis based on product, technique, application, and region
• In-depth information (facts and figures) pertaining to the major market dynamics, R&D efforts, current status on MedTech, upcoming technologies, future demand in clinical diagnostics, and regulatory scenarios; and the impacts of COVID-19 pandemic on the worldwide market
• Identification of the companies that are best positioned to meet the surging demand for innovations in PCR technology, owing to or in conjunction with their proprietary technologies, strategic alliances, and other competitive advantages
• Discussion of sustainability trends and factors in emerging materials in the PCR market, with emphasis on consumer attitudes, ESG score analysis, future of ESG, and the ESG practices followed
• An overview of the major vendors in the global PCR market along with an analysis of the structure of the industry, including company market shares and recent mergers and acquisitions (M&A) activity
• Review of both new and existing patents on PCR technologies and their applications in molecular diagnosis of infectious diseases
• Profiles of the leading global players, including F. Hoffmann-LaRoche, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Becton, Dickinson and Company, and Danaher Corp.

Table of Contents

Chapter 1 Introduction

• Study Goals and Objectives
• Reasons for Doing This Study
• Scope of Report
• What's New in This Update?
• Methodology and Information Sources
• Geographic Breakdown
• Segmentation Breakdown

Chapter 2 Summary and Highlights

• Market Outlook
• Highlights of the PCR Market

Chapter 3 Market Overview

• Overview
• Evolution of PCR
• Principles of PCR
• Instruments and Components of PCR
• Instruments
• Target DNA
• Primers
• Enzyme and Enzyme Concentration
• Buffers
• Magnesium Concentration
• Deoxyribonucleoside Triphosphates
• Traditional vs. Real-Time PCR
• Design of Primers for PCR
• Primer Selection
• Primer Length
• Melting Temperature
• Specificity
• G/C Content
• 3' End Sequence
• PCR Quantification Methods
• Absolute Quantification
• Relative Quantification
• Components of Quantitative PCR
• DNA Binding Dyes
• Probes in qPCR
• Controls for qPCR Experiments

Chapter 4 Market Dynamics

• Market Drivers
• COVID-19
• Technology Advancements
• Growing Demand in Clinical Diagnostics
• Growth in Genomic and Biomarker Research
• Robust Demand in Industrial Applications
• Market Challenges
• High Investment Cost
• Lack of Trained Professionals
• Technical Limitations and Competition from Alternative Technologies
• Stringent Regulatory Landscape
• Key Factors, Impact on Market

Chapter 5 Market Breakdown by Technique

• Market Overview
• Standard PCR (PCR)
• Reverse Transcription PCR (RT-PCR)
• Quantitative Real-Time PCR
• Quantitative Real-Time PCR (qPCR)
• Quantitative Real-Time Reverse Transcription PCR (RT-qPCR)
• Multiplex PCR
• Digital PCR (dPCR)
• Other PCR Techniques
• Nested
• Touchdown
• Hot-Start
• Inverse PCR
• Market Revenue by Technique
• Quantitative Real-Time PCR (qPCR and RT-qPCR)
• Standard PCR
• Reverse Transcription PCR (RT-PCR)
• Multiplex PCR
• Digital PCR (dPCR)
• Other PCRs

Chapter 6 Market Breakdown by Product

• Market Overview
• Global Market for PCR, by Product
• Instruments
• Market Overview
• Market Revenue by Type
• Market Revenue by Region
• Reagents and Consumables
• Market Overview
• Market Revenue by Type
• Market Revenue by Region
• Software and Services
• Market Overview
• Market Revenue by Type
• Market Revenue by Region

Chapter 7 Market Breakdown by Application

• Overview
• Basic Research Applications
• Market Overview
• Market Revenue by Region
• Clinical Applications
• Market Overview
• Market Revenue by Region
• Industrial Applications
• Market Overview
• Market Revenue by Region

Chapter 8 Market Breakdown by Region

• Market Overview
• Market Revenue, by Region
• North America
• Market Revenue, by Country
• Europe
• Market Revenue, by Country
• Asia-Pacific
• Market Revenue, by Country
• Rest of the World (RoW)

Chapter 9 ESG Development

• Introduction to ESG
• Sustainability in PCR Industry: An ESG Perspective
• Key Environmental Issues
• Industry ESG Performance Analysis
• Concluding Remarks from BCC Research

Chapter 10 Emerging Technologies and Developments

• Overview
• Digital PCR
• Multiplex PCR Syndromic Testing
• Point-of-Care & Decentralization of PCR Testing
• Isothermal Nucleic Acid Amplification Techniques (INAATs)
• PCR Automation

Chapter 11 Patent Analysis

• Patents
• PubMed

Chapter 12 Competitive Intelligence

• Overview
• Instruments
• Reagents, Consumables, and Accessories
• Leading players
• Mergers and Acquisitions

Chapter 13 Company Profiles

• ABBOTT
• AGILENT TECHNOLOGIES, INC.
• BECTON, DICKINSON AND CO.
• BIOMERIEUX
• BIO-RAD LABORATORIES INC.
• DANAHER
• EPPENDORF SE
• EUROFINS SCIENTIFIC
• F. HOFFMANN-LA ROCHE LTD.
• HOLOGIC
• MERCK KGAA
• QIAGEN
• STANDARD BIOTOOLS INC.
• SYSMEX INOSTICS, INC.
• TAKARA BIO INC.
• THERMO FISHER SCIENTIFIC INC.

Chapter 14 Appendix: Acronyms